{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T03:14:27Z","timestamp":1766546067758,"version":"3.37.3"},"reference-count":62,"publisher":"Informa UK Limited","issue":"3","funder":[{"name":"NIH","award":["P30 DK-090868"],"award-info":[{"award-number":["P30 DK-090868"]}]},{"DOI":"10.13039\/100000133","name":"AHRQ","doi-asserted-by":"crossref","award":["RO1 HS-018975"],"award-info":[{"award-number":["RO1 HS-018975"]}],"id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Investigational Drugs"],"published-print":{"date-parts":[[2016,3,3]]},"DOI":"10.1517\/13543784.2016.1148137","type":"journal-article","created":{"date-parts":[[2016,1,29]],"date-time":"2016-01-29T07:36:18Z","timestamp":1454052978000},"page":"263-273","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":28,"title":["Integrin antagonists as potential therapeutic options for the treatment of Crohn\u2019s disease"],"prefix":"10.1517","volume":"25","author":[{"given":"Leon P.","family":"McLean","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond K.","family":"Cross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2016,2,22]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2011.10.001"},{"issue":"1","key":"CIT0002","first-page":"S3S9","volume":"12","author":"Hanauer SB.","year":"2006","journal-title":"Inflamm Bowel Dis"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.01.063"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1038\/nature06005"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1136\/gut.35.5.696"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-014-3368-z"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-2980.2010.00449.x"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2008.01962.x"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1097\/00054725-200411000-00019"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.08.001"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.109.153973"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2168.2000.01589.x"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.2165\/00063030-200822040-00005"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2011.04612.x"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.2217\/imt.12.85"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1016\/S0300-8932(09)71035-8"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1586\/eci.10.40"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1111\/bph.12134"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.03.024"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043335"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1136\/practneurol-2011-000092"},{"volume-title":"TYSABRI(R), prescribing information","year":"2012","author":"Biogen Idec, Inc.","key":"CIT0022"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000373"},{"issue":"1","key":"CIT0024","first-page":"97","volume":"151","author":"Briskin M","year":"1997","journal-title":"Am J Pathol"},{"issue":"1","key":"CIT0026","doi-asserted-by":"crossref","first-page":"S4S5","DOI":"10.1002\/ibd.21347","volume":"17","author":"Fedyk E","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1215739"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1215734"},{"volume-title":"FDA approves Entyvio to treat ulcerative colitis and Crohn\u2019s disease","year":"2014","author":"United States Food and Drug Administration","key":"CIT0029"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.05.008"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2011-301769"},{"issue":"8","key":"CIT0032","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.4049\/jimmunol.150.8.3459","volume":"150","author":"Cepek KL","year":"1993","journal-title":"J Immunol"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830250333"},{"issue":"11","key":"CIT0034","doi-asserted-by":"crossref","first-page":"6641","DOI":"10.4049\/jimmunol.162.11.6641","volume":"162","author":"Schon MP","year":"1999","journal-title":"J Immunol"},{"issue":"3","key":"CIT0035","first-page":"288","volume":"61","author":"Elewaut D","year":"1998","journal-title":"Acta Gastroenterol Belg"},{"issue":"5","key":"CIT0036","first-page":"715","volume":"12","author":"Oshitani N","year":"2003","journal-title":"Int J Mol Med"},{"issue":"8","key":"CIT0037","doi-asserted-by":"crossref","first-page":"4975","DOI":"10.4049\/jimmunol.162.8.4975","volume":"162","author":"Ludviksson BR","year":"1999","journal-title":"J Immunol"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2011.01205.x"},{"key":"CIT0039","doi-asserted-by":"publisher","DOI":"10.1177\/0192623311430237"},{"key":"CIT0040","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60661-9"},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(09)60816-7"},{"key":"CIT0042","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.08.044"},{"key":"CIT0043","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12418"},{"key":"CIT0044","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2010.226548"},{"key":"CIT0045","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.01.037"},{"key":"CIT0046","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2006.11.001"},{"volume-title":"Open-label extension and safety study for patients with Crohn\u2019s disease previously enrolled in the etrolizumab phase III study GA29144","year":"2015","author":"National Institutes of Health","key":"CIT0047"},{"volume-title":"Open-label extension and safety study for patients with ulcerative colitis previously enrolled in etrolizumab phase III studies","year":"2015","author":"National Institutes of Health","key":"CIT0048"},{"volume-title":"A study comparing the efficacy and safety of etrolizumab with adalimumab and placebo in patients with moderate to severe ulcerative colitis in patients naive to TNF inhibitors (Study #1)","year":"2015","author":"National Institutes of Health","key":"CIT0049"},{"volume-title":"A study comparing the efficacy and safety of etrolizumab with adalimumab and placebo in patients with moderate to severe ulcerative colitis in patients naive to TNF inhibitors (Study #2)","year":"2015","author":"National Institutes of Health","key":"CIT0050"},{"volume-title":"A study comparing the efficacy and safety of etrolizumab to infliximab in patients with moderate to severe ulcerative colitis who are naive to TNF inhibitors","year":"2015","author":"National Institutes of Health","key":"CIT0051"},{"volume-title":"A study of the efficacy and safety of etrolizumab treatment in maintenance of disease remission in ulcerative colitis patients who are naive to TNF inhibitors","year":"2015","author":"National Institutes of Health","key":"CIT0052"},{"volume-title":"A study of the efficacy and safety of etrolizumab in ulcerative colitis patients who are refractory to or intolerant of TNF inhibitors","year":"2015","author":"National Institutes of Health","key":"CIT0053"},{"key":"CIT0054","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2013.03.014"},{"volume-title":"AMG 181 in subjects with moderate to severe Crohn\u2019s disease","year":"2015","author":"National Institutes of Health","key":"CIT0055"},{"volume-title":"Study to test whether PF-00547659 is safe and improves disease symptoms in patients with Crohn\u2019s disease (OPERA)","year":"2015","author":"National Institutes of Health","key":"CIT0056"},{"issue":"9","key":"CIT0057","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.4049\/jimmunol.147.9.2913","volume":"147","author":"Oppenheimer-Marks N","year":"1991","journal-title":"J Immunol"},{"key":"CIT0058","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830210719"},{"key":"CIT0059","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830180423"},{"volume-title":"Randomized study of topical alicaforsen enema in antibiotic refractory pouchitis","year":"2015","author":"National Institutes of Health","key":"CIT0060"},{"key":"CIT0061","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2013.11.003"},{"issue":"5","key":"CIT0062","first-page":"S","volume":"146","author":"Sandborn WJ","year":"2014","journal-title":"Gastroenterology"},{"key":"CIT0063","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000561"}],"container-title":["Expert Opinion on Investigational Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/13543784.2016.1148137","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T17:29:00Z","timestamp":1692206940000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1517\/13543784.2016.1148137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,22]]},"references-count":62,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,1,12]]},"published-print":{"date-parts":[[2016,3,3]]}},"alternative-id":["10.1517\/13543784.2016.1148137"],"URL":"https:\/\/doi.org\/10.1517\/13543784.2016.1148137","relation":{},"ISSN":["1354-3784","1744-7658"],"issn-type":[{"type":"print","value":"1354-3784"},{"type":"electronic","value":"1744-7658"}],"subject":[],"published":{"date-parts":[[2016,2,22]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieid20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieid20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"}]}}